Hypertension
Conditions
Keywords
HTN, Hypertension, Qurs e Fishar
Brief summary
The herbal medicine Qurs-e-Fishar to treat mild to moderate High blood pressure or hypertension comprises of Rauwolfia serpentina. A product of Hamdard Laboratories (Waqf) Pakistan. A Phase III Safety & Efficacy Open-label, Single-Arm, Interventional, Multicenter, Study in mild to moderate hypertensive, adults (30 to 60 years of age) prescribed with study product for 12 weeks (84 days). Primary End Points: 1. Reduction in diastolic blood pressure less than 130 / 80 mmHg at the end of the study period (accepted by WHO) or if there was a fall of 20 / 10 mmHg or more in diastolic blood pressure as compared to baseline. 2. Type, frequency and severity of ADRs during the study period. Secondary End Points: 1\. Compliance of the prescribed study medication.
Interventions
OTHERQurs e Fishar
Qurs e Fishar is a herbal remedy for Hypertension
Sponsors
Hamdard University
Abdul Bari
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Ability to sign ICD * Participant(s) are willing and able to fulfill the requirements of the study protocol * Mild to moderate hypertensive * Mild hypertension range (140-159/90-99 mm Hg) * Moderate hypertension range (160-179/100-109 mm Hg) * Be between the age of 30 to 60 year
Exclusion criteria
* Patients with recent history of following will be excluded: * Severe hypertension, * Congestive cardiac failure, * Left ventricular failure, * Myocardial ischemia, * Renal failure or * Cerebrovascular accidents
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood Pressure | 12 weeks | Blood pressure (in mmHg) will be measure at baseline and again at first follow-up (4th week), than at second follow-up (at 8th week) the end of treatment (12th week). |
Countries
Pakistan
Outcome results
None listed